title: Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
abstract: Platelets, as main actors of the first stage of the healing process, play an important role in tissue repair. Their granules contain many active substances, particularly over 30 growth factors with significant effects on the resident cells at the site of injury, such as mesenchymal stem cells, chondrocytes, fibroblasts, osteoblasts. This potential may be increased by the concentration of the platelets, using platelet-rich plasma/fibrin products. In the four families of platelet concentrates, 2 families contain also significant concentrations of leukocytes: L-PRP (Leukocyte- and Platelet-Rich Plasma) and L-PRF (Leukocyte- and Platelet-Rich Fibrin). Inductive properties of platelet concentrates were widely described. However, they present also antimicrobial effects. The antibacterial effects of L-PRP were highlighted in only a few in vitro studies. Strong activity comparable to gentamicin and oxacillin for L-PRP against methicillin susceptible Staphylococcus aureus (MSSA) was already demonstrated. L-PRP also inhibited the growth of methicillin resistant Staphylococcus aureus (MRSA) and Escherichia coli. Some authors also reported clinical observations about the reduction of infections and the induction of healing processes after the use of platelet concentrates in cardiac, orthopaedic, oral and maxillofacial surgery. However, very little is yet known about the antibacterial effects of these concentrates. In this manuscript, the current data about the antimicrobial agents and cells present in the platelet-rich plasma/fibrin are highlighted and discussed, in order to introduce this new key chapter of the platelet concentrate technology history.
authors: Department and Clinic of Cranio and Maxillofacial Surgery, Medical University of Silesia, Katowice, Poland.
authors: A
authors: A
authors: Cieslik-Bielecka
authors: D M
authors: DM
authors: Dohan Ehrenfest
authors: A
authors: A
authors: Lubkowska
authors: T
authors: T
authors: Bielecki
mesh_terms: D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology; D001792:Blood Platelets / Q000737:chemistry*; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D005337:Fibrin / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000096:biosynthesis / Q000627:therapeutic use*; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development; D050296:Microbial Viability / Q000187:drug effects*; D009504:Neutrophils / Q000737:chemistry; D053657:Platelet-Rich Plasma / Q000737:chemistry* / Q000166:cytology; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology; D023084:alpha-Defensins / Q000096:biosynthesis / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D036341:Intercellular Signaling Peptides and Proteins; D023084:alpha-Defensins; D005337:Fibrin